Extreme Drug Resistant Acinetobacter Nosocomial Ventilator-Associated Pneumonia Treated Successfully with Tigecycline and Amikacin in Intensive Care Unit: A Case Report.
10.4266/kjccm.2009.24.3.176
- Author:
So Yeon LIM
1
;
So Young PARK
;
Kyeongman JEON
;
Gee Young SUH
;
Suhyun KIM
;
Kyong Ran PECK
;
Doo Ryeon CHUNG
Author Information
1. Division of Pulmonary and Critical Care Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
- Publication Type:Case Report
- Keywords:
acinetobacter;
amikacin;
tigecycline;
ventilator-associated pneumonia
- MeSH:
Acinetobacter;
Acinetobacter baumannii;
Amikacin;
Humans;
Critical Care;
Intensive Care Units;
Minocycline;
Pneumonia, Ventilator-Associated
- From:The Korean Journal of Critical Care Medicine
2009;24(3):176-180
- CountryRepublic of Korea
- Language:Korean
-
Abstract:
Infections due to multidrug resistant Acinetobacter baumannii have become a challenging problem in intensive care units. Tigecycline is a derivative of minocyline, and has provided new hope for the treatment of multidrug-resistant A. baumannii infections. Because isolates showing reduced susceptibility to minocycline or tigecycline have emerged in many countries, empirical combination therapy has become common practice to treat patients infected with extreme drug-resistant A. baumannii. Herein we report a case of extreme drug-resistant A. baumannii infection successfully treated with tigecycline and amikacin.
